Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-015421
Filing Date
2025-04-24
Accepted
2025-04-24 16:05:30
Documents
18
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20045110x1_def14a.htm   iXBRL DEF 14A 644511
6 logo_immunome2.jpg GRAPHIC 43869
7 ny20045110x1_pc01.jpg GRAPHIC 587861
8 ny20045110x1_pc02.jpg GRAPHIC 634699
  Complete submission text file 0001140361-25-015421.txt   4372884

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA imnm-20250610.xsd EX-101.SCH 3395
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE imnm-20250610_def.xml EX-101.DEF 3086
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE imnm-20250610_lab.xml EX-101.LAB 2329
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE imnm-20250610_pre.xml EX-101.PRE 6900
20 EXTRACTED XBRL INSTANCE DOCUMENT ny20045110x1_def14a_htm.xml XML 67565
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39580 | Film No.: 25867264
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)